Plain-English translation of NCT06468774 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is looking for a reliable blood test that could help doctors diagnose two conditions where the bowel doesn't get enough blood flow: chronic mesenteric ischemia (caused by blocked arteries) and median arcuate ligament syndrome (caused by a ligament pressing on blood vessels). The study measures a protein called Alpha GST in blood samples to see if it could become a simple diagnostic tool.
Currently, doctors have no quick blood test to diagnose these bowel blood flow conditions—they have to rule out many other diseases first, which delays treatment and causes patients to suffer longer. This study aims to see if measuring this protein could provide a faster, more reliable way to identify who truly needs surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the hospital to have blood drawn before any treatment (if you're in the patient groups) or at enrollment (if you're a healthy volunteer or have another condition). You'll have a second blood draw about three months later. If you're in a control group, you'll also have an ultrasound scan to confirm you don't have bowel blood flow problems. The blood samples are stored and later analyzed in a laboratory to measure the protein being studied.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
Norway